Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China flag China · Delayed Price · Currency is CNY
25.00
-0.45 (-1.77%)
At close: Feb 13, 2026

SHA:600645 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,1201,5251,5811,3931,1961,060
Trading Asset Securities
543.18-----
Cash & Short-Term Investments
1,6631,5251,5811,3931,1961,060
Cash Growth
15.64%-3.56%13.48%16.54%12.76%2.61%
Accounts Receivable
637.85644.94610.53575.98510.95512.64
Other Receivables
15.7611.618.0928.4116.5828.24
Receivables
653.61656.54628.62604.39527.53540.88
Inventory
237.24232.19247.9248.09226.96222.4
Prepaid Expenses
-0.512.386.482.98-
Other Current Assets
41.9242.0848.3657.6477.0891.51
Total Current Assets
2,5962,4562,5082,3102,0301,915
Property, Plant & Equipment
641.82688.71705.33765.54766.09733.46
Long-Term Investments
745.68736.84779.96804.31886.53872.49
Goodwill
702.91702.91702.91702.91702.91722.63
Other Intangible Assets
89.38100.45101.42111.73133.96147.95
Long-Term Accounts Receivable
20.7428.4737.455265.968.95
Long-Term Deferred Tax Assets
91.7992.9581.856.0246.9447.83
Long-Term Deferred Charges
160.07165.22159.98148.88141.13130.63
Other Long-Term Assets
268.81277.08334333.2259.72240.52
Total Assets
5,3175,2495,4115,2855,0334,880
Accounts Payable
121.0647.3268.7656.8532.1243.21
Accrued Expenses
70.86170.15146.96134.91132.33120.21
Current Portion of Long-Term Debt
--6.316.316.319.34
Current Portion of Leases
21.1243.7523.3421.1916.69-
Current Income Taxes Payable
35.316.7117.9330.3824.9720.99
Current Unearned Revenue
1,1291,1341,1371,1121,0781,024
Other Current Liabilities
93.6985.481.29109.64105.5682.41
Total Current Liabilities
1,4711,4871,4821,4711,3961,300
Long-Term Debt
--9.4615.7722.0837.53
Long-Term Leases
51.538088.3797.937.1111.6
Long-Term Unearned Revenue
9.689.5610.0210.9211.0813.64
Long-Term Deferred Tax Liabilities
11.6912.9523.1534.8734.714.41
Other Long-Term Liabilities
11.6-----
Total Liabilities
1,5561,5901,6131,6311,5011,377
Common Stock
467.95467.95467.95467.95467.95467.95
Additional Paid-In Capital
3,3903,3743,3773,3843,3833,378
Retained Earnings
-86.02-193.92-294.27-400.73-513.71-687.7
Treasury Stock
-200.03-200.03----
Comprehensive Income & Other
139.33147.54133.31104.7125.98238.53
Total Common Equity
3,7113,5953,6843,5563,4633,396
Minority Interest
50.563.98114.5597.8569.31106.03
Shareholders' Equity
3,7623,6593,7993,6543,5333,502
Total Liabilities & Equity
5,3175,2495,4115,2855,0334,880
Total Debt
72.65123.75127.48141.1882.258.48
Net Cash (Debt)
1,5911,4011,4541,2521,1131,002
Net Cash Growth
21.02%-3.61%16.09%12.46%11.14%11.58%
Net Cash Per Share
3.553.073.142.662.372.13
Filing Date Shares Outstanding
455.9455.9467.95467.95467.95467.95
Total Common Shares Outstanding
455.9455.9467.95467.95467.95467.95
Working Capital
1,125968.931,027838.53634.56615.09
Book Value Per Share
8.147.897.877.607.407.26
Tangible Book Value
2,9192,7922,8802,7412,6272,526
Tangible Book Value Per Share
6.406.126.155.865.615.40
Land
-3.543.493.433.143.21
Buildings
-546.68482.6497.7558.38560.89
Machinery
-700.82690.88653.02623.86583.77
Construction In Progress
-10.5418.9823.2320.58.06
Source: S&P Global Market Intelligence. Standard template. Financial Sources.